Study of Difluprednate in the Treatment of Uveitis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
2 Years and older (Child, Adult, Older Adult)
Sexes Eligible for Study:
Diagnosis of endogenous anterior uveitis in at least 1 eye
Presence of intermediate uveitis, posterior uveitis or panuveitis
Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease
Allergy to similar drugs, such as other corticosteroids